Noninfectious pulmonary complications of hematopoietic stem cell transplant are currently more prevalent than infectious complications. Unfortunately, the pathophysiology basis is not completely understood. However, there is a string association with graft-versus-host disease for many of them. Therefore, an important component of their pathophysiology is likely an allo-immune response. There is much research that needs to be conducted to improve the less than optimal outcomes for these disorders
Pulmonary complications resulting in high morbidity and mortality occur in a Substantial proportion ...
Patients who have received haematopoietic stem cell transplantation (HSCT) have a high rate of pulmo...
12We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmon...
Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignan...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Pediatric data about early or long-term pulmonary complications of hematopoietic stem cell transplan...
Effect on survival of the development of late-onset non-infectious pulmonary complications after ste...
Alloimmune lung syndromes (allo-LS), including idiopathic pneumonia syndrome, bronchiolitis oblitera...
Pulmonary complications are common in children following hematopoietic cell transplantation (HCT) an...
AbstractPulmonary complications are important cause of mortality and morbidity after hematopoietic s...
AbstractPulmonary hypertension (PH) is a potentially fatal complication of hematopoietic stem cell t...
Nonmyeloablative conditioning before allogeneic hematopoietic cell transplant (HCT) is an alternativ...
Alloimmune lung syndromes (allo-LS), including idiopathic pneumonia syndrome, bronchiolitis oblitera...
Of 50,000 to 60,000 hematopoietic stem cell trans-plants (HSCTs) performed annually, 35,000 to 40,00...
Pulmonary complications resulting in high morbidity and mortality occur in a Substantial proportion ...
Patients who have received haematopoietic stem cell transplantation (HSCT) have a high rate of pulmo...
12We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmon...
Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignan...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Pediatric data about early or long-term pulmonary complications of hematopoietic stem cell transplan...
Effect on survival of the development of late-onset non-infectious pulmonary complications after ste...
Alloimmune lung syndromes (allo-LS), including idiopathic pneumonia syndrome, bronchiolitis oblitera...
Pulmonary complications are common in children following hematopoietic cell transplantation (HCT) an...
AbstractPulmonary complications are important cause of mortality and morbidity after hematopoietic s...
AbstractPulmonary hypertension (PH) is a potentially fatal complication of hematopoietic stem cell t...
Nonmyeloablative conditioning before allogeneic hematopoietic cell transplant (HCT) is an alternativ...
Alloimmune lung syndromes (allo-LS), including idiopathic pneumonia syndrome, bronchiolitis oblitera...
Of 50,000 to 60,000 hematopoietic stem cell trans-plants (HSCTs) performed annually, 35,000 to 40,00...
Pulmonary complications resulting in high morbidity and mortality occur in a Substantial proportion ...
Patients who have received haematopoietic stem cell transplantation (HSCT) have a high rate of pulmo...
12We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmon...